Penserra Capital Management LLC Global Blood Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$24.9 - $40.26 $35,607 - $57,571	-1,430 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $382 - $560	15 Added 1.06%	1,430 $36,000
Q2 2021 Aug 12, 2021	BUY	$32.46 - $43.42 $162 - $217	5 Added 0.35%	1,415 $49,000
Q1 2021 May 13, 2021	SELL	$38.94 - $50.85 $584 - $762	-15 Reduced 1.05%	1,410 $57,000
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $33,847 - $57,329	899 Added 170.91%	1,425 $61,000
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $27,751 - $39,181	526 New	526 $29,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.